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Traumatic brain injury is a major global cause of death and disability. Axonal injury is
a major underlying mechanism of TBI and could represent a major therapeutic target.
We provide evidence that targeting the axonal death pathway known as Wallerian
degeneration improves outcome in a Drosophila Melanogaster model of high impact
trauma. This cell-autonomous neurodegenerative pathway is initiated following axon
injury, and in Drosophila, involves activity of the E3 ubiquitin ligase highwire. We
demonstrate that a loss-of-function mutation in the highwire gene rescues deleterious
effects of a traumatic injury, including—improved functional outcomes, lifespan, survival
of dopaminergic neurons, and retention of synaptic proteins. This data suggests that
highwire represents a potential therapeutic target in traumatic injury.
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INTRODUCTION
Traumatic brain injury (TBI) is defined as an alteration in brain function, or other evidence of brain
pathology, caused by an external force (1). It is a major cause of death and disability, and each year
in Europe alone ∼2.5 million people will experience TBI, 1 million of which will be admitted to
hospital, and 75,000 will die (2). Various secondary injury cascades follow the initial primary insult
of TBI, promoting ongoing neuronal cell loss. The secondary injury response is multifaceted and
comprises a number of processes including Wallerian degeneration (WD) (3).
WD is an active, cell-autonomous death pathway that leads to degeneration of the distal axonal
segment following transection (4). In some neuronal subtypes WD following axonal injury may
lead to a progressive dying back of the proximal axon segment and death of the neuronal cell
body (5). A related process, Wallerian-like degeneration, occurs through the same molecular
mechanisms as WD but does not require a complete axonal transection and instead is typically
characterized by an impairment of axonal transport (4). WD and Wallerian-like degeneration
are both thought to play a role in secondary brain injury following TBI although complete
axotomy that occurs at the time of an injury (primary axotomy) is uncommon, and the degree to
which sub-axotomy level injuries subsequently impair axonal transport and induce Wallerian-like
degeneration remains incompletely characterized (6–10).
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Activation of the WD pathway is fundamentally linked to
the nicotinamide adenine dinucleotide NAD synthetic pathway
(Supplementary Figure 1A). Nicotinamide mononucleotide
adenylyl transferase (NMNAT) is a key enzyme in the
WD/Wallerian-like degeneration pathway, converting
nicotinamide mononucleotide (NMN) to nicotinamide adenine
dinucleotide (NAD). NMNAT also displays chaperone function
during stress responses (11–15). Following transection, the
delivery of the axonal isoform of NMNAT (NMNAT2) from
the neuronal cell body to the distal axon is compromised. As
NMNAT2 is degraded NMN accumulates and levels of NAD fall
(13, 16–18). This results in activation of the toll-like receptor
adaptor protein; sterile motif-containing and armadillo-motif
containing protein (SARM1) resulting in axon fragmentation
(Supplementary Figure 1B) (19–23). This mechanism of
axon degeneration is conserved across species. In Drosophila
Melanogaster, only one isoform of NMNAT is present, this is
called dNMNAT (drosophila NMNAT) and serves the functions
of mammalian NMNAT 1-3 isoforms, including delay in
Wallerian degeneration. NMNAT proteins are evolutionarily
conserved and dNMNAT can directly substitute for NMNAT
isoforms in mammalian systems (24–28).
Evidence for a role of WD/ Wallerian-like degeneration in
TBI has emerged from rodent cortical-contusion injury studies.
The first WD gene to be explored in a model of TBI was the
slow Wallerian degeneration gene (Wlds). This gene encodes a
mutant protein (WLDs) that can substitute for NMNAT, and
Wlds expressing mice demonstrate less motor and cognitive
impairment following a cortical-contusion injury (29). Similarly,
knockout of SARM1 was associated with reduced neuronal
loss and cognitive impairment following CCI (30). These
studies suggest that therapeutic modulation of the Wallerian-
like degeneration pathway may be possible, and potentially could
improve outcomes from TBI (3).
Another tractable context to explore the biology of WD
is Drosophila Melanogaster. Loss-of-function mutations in the
highwire (hiw) gene in D. Melanogaster are associated with a
strong delay in axon degeneration following transection both
in vitro and in vivo (24, 31–33). Delayed WD is also seen with
mutations in the mammalian ortholog of hiw; PHR1 (4, 34, 35).
The hiw gene encodes a large 5233 amino acid protein with
E3 ubiquitin ligase activity that modulates levels of dNMNAT
(24, 31, 35, 36).Hiw also has presynaptic regulatory activity that is
required to control excess synaptic growth at the neuromuscular
junction (31, 36, 37). To investigate for potential modifiers of
brain trauma we utilized a model of high impact trauma (HIT)
in D. Melanogaster in which WD pathways show extensive
conservation with mammalian species (4, 19, 20, 35, 38–40).
Given the role of hiw in dNMNAT depletion and subsequent
axon degeneration, and the assessment that Wallerian-like
degeneration may contribute to the secondary brain injury seen
in TBI, we hypothesized that flies with a null mutation in hiw
(hiw1N) would show protection against the effects of TBI. We
show that hiw1N flies showed relative protection against long-
termmortality and cell death. Brain vacuolation and necrotic cell
death occurred regardless of genotype—suggesting that the hiw
mutants still underwent a neurodegenerative process but there
was reduced presynaptic marker depletion and dopaminergic
(PPL1) neuron loss. This suggests that a subset of vulnerable—
but functionally important- neurons may be rescued by hiw
loss-of-function. This translated to a preservation of normal
behavioral measures. These findings suggest that hiw and its
mammalian ortholog PHR1 are potential therapeutic targets in
experimental and clinical TBI.
MATERIALS AND METHODS
Drosophila Melanogaster Stocks
and Conditions
Hiw mutant hiw1N and control hiwWT (FRT19A) flies were
obtained from Marc Freeman (University of Massachusetts).
Newly enclosed flies were collected daily, separated by sex,
into vials of 20–35 flies, and aged for experimental use. All
experiments were conducted on flies aged 1–4 days unless
otherwise stated. All flies were maintained at a constant
25◦C temperature and humidity, in glass vials with standard
agar/cornmeal/yeast feed. Flies were exposed to a 12 h light-dark
cycle. Feed was changed in all vials once every 14 days or sooner
as required. All experiments were conducted exclusively on male
flies in order to avoid confounding effects relating to the female
reproductive cycle.
High Impact Trauma Device, Injury
Calibration, Incapacitation Rates, and
Intestinal Barrier Dysfunction
Flies were subjected to a standardized impact with the HIT
device. After injury, vials were laid on their side and flies were
given a minimum of 10min to recover motility before being
transferred to a glass vial containing standardized feed. All
polystyrene vials were discarded after a single use. The severity
of injury was calibrated in hiwWT flies by assessing the death
rates 24 h following HIT when the angle of initial deflection, and
thus recoil force, was adjusted. Incapacitation rates were recorded
by assessing the percentage of flies that failed to show signs of
purposeful movement within 20 seconds of initial impact. To
evaluate intestinal barrier dysfunction following HIT flies were
transferred to feed containing dissolved Brilliant Blue FCF dye
(#80717, Sigma). After 24 h the percentage of flies that had blue
food dye dispersed outside of the abdominal cavity and proboscis
were counted.
Early Death Rate and Long-Term
Survival Assay
To assess for variation in early death rates we exposed flies to
a HIT at a standardized time of day (09:00 h). Any flies dying
immediately or within the first 24 h of a HIT were considered to
have died of the undifferentiated primary effects of a HIT. Dead
flies were removed and all remaining live flies were transferred to
new vials and long-term survival was monitored. A daily count of
number of fly deaths was conducted in all vials for the lifetime of
all flies. Dead flies were discarded every day.
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Rapid Iterative Negative Geotaxis (RING)
Assay and Flight Assay
A custom made rapid iterative negative geotaxis (RING)
device was manufactured and used to measure negative
geotaxis/climbing ability as a behavioral measure of motor
function (41, 42). Flies were gently transferred to fresh empty
polystyrene vials without anesthesia with a maximum density
of 25 flies per vial. Groups of up to 6 vials were inserted into
the RING device, and after 5min for the flies to adjust to the
environmental change the device was tapped three times to settle
flies to the bottom of the vials. Exactly 5 s after the last tap a
photograph was taken to assess the height climbed. The head of
the fly was the reference point for the climbing height achieved.
Maximum height achieved was graded into 5mm intervals, flies
that climbed <5mm were scored zero, and any fly that exceeded
50mm was awarded the maximum score was 5 cm. The average
height achieved for the vial was calculated. This was repeated
3 times at 60 s intervals and an average score given for that
vial. The climbing ability was calculated on a vial by vial basis.
For the flight assay, flies were anesthetized on ice for exactly
5min then the flat of a 30G 1” needle (#Z192368, Sigma) was
attached to the anterior notum of a fly just posterior to the
neck using clear nail varnish, leaving flight muscles unimpeded.
Flies were given 15min to fully recover. Needles were fixed
in place under a video microscope. If required then a gentle
mouth-blown puff of air was used to stimulate flight and the
flying time was recorded for 30 s per fly for analysis. This
was repeated 3 times per fly and the average of time spent in
flight was calculated for each condition. This was a terminal
assay. We maintained standardized conditions using the same
experimental setup for each range of experimental condition
in both the climbing and flying assay. The same experimenter
conducted all experiments in a standardized fashion, in a single
laboratory room, at the same time of day (09:00), and with
the same equipment and environmental conditions—including
room lighting and 25 degrees temperature).
Haematoxylin and Eosin Histology, and
Vacuole Counting
Anesthetized flies were submerged in cold 1x PBS, the proboscis
and rostral trachea were removed, and the amputated heads
gently rocked in fresh ice cold 4% paraformaldehyde solution for
45min. Brain extraction is not necessary for high-quality H&E
analysis so brains were stained in situ within the cuticle. The
tissue was alcohol dehydrated, xylene washed, and embedded in
paraffin for serial sectioning with a microtome (Leica RM2235)
at a thickness 7 µM. Sections were mounted on poly-L-lysine
coated slides (P0245, Sigma). Wax was removed with a xylene
bath then alcohol washes before haematoxylin and eosin staining,
and application of coverslips. After blinding, three representative
coronal sections were examined from a central brain region that
included the medulla using brightfield microscopy. The average
number of≥5µMvacuoles per slice in each brain was calculated.
Vacuoles were measured at the greatest diameter—microscopy
photographs were analyzed using image J software (v1.51n). All
image analysis was performed with the investigator blinded to
experimental conditions.
Immunohistochemistry
Fly brains were dissected in cold 1x PBS and fixed in
4% paraformaldehyde-PBS for 30min. Brains were dissected
for immunohistochemical analysis as penetration of antibody
through the waxy cuticle is limited and would otherwise be
inaccurate. Samples were washed in 1x PBS with 0.3% Triton X-
100 (#T8787, Sigma) and blocked for 1 h at room temperature
in 1x PBS with 0.3% Trition X-100 and 1% BSA (#9647, Sigma).
Brains were incubated in primary antibody diluted with blocking
solution for 72 h. After washing and incubating in a fluorescent
secondary antibody solution for 4 h, samples were washed
and mounted between two coverslips in ProLong diamond
antifade mountant (#P36965, ThermoFisher). Confocal images
were acquired on a Leica imaging system, at z-stack intervals
not greater than 0.6 µM and blinded for analysis. Primary
antibodies used were mouse Tyrosine-Hydroxylase (anti-TH)
antibody 1:100 (TH-antibody, #22941, Immunostar Inc.) for
the PPL1 cluster. Secondary antibodies were goat anti-mouse
IgG (H+L) Alexa Fluor 488 (#A11034, ThermoFisher), and
donkey anti-rabbit IgG (H+L) Alexa Fluor 594 (##21207). All
image analysis was performed with the investigator blinded to
experimental conditions. For each brain a Z-stack was taken that
covered the entire extent of the fixed brain. Each Z-stack was
set at a slice thickness of 0.5µm. There were 1 or 2 regions of
interest per brain depending on the quality of dissection. The
PPL1 cluster is identified by its location and its characteristics
major neuropil projections to the mushroom bodies and vicinity,
this is clearly different from neurons in other adjacent clusters
(43). A total of 10–12 PPL1 clusters were used per condition, this
equates to 5–12 brains. All brains were immunolabelled using
a standardized method in parallel at a single time point. Image
settings were kept constant throughout all analysis. Images were
analyzed using image J software (v1.51n).
Immunoblotting
Fifteen whole fly heads were collected and homogenized in
Laemmli sample buffer and centrifuged 13,000 rpm for 5min.
Supernatant protein lysates were resolved by SDS-PAGE on
Mini-protean 4-15% SDS resolving gel (#4561086, Bio-Rad) and
transferred to Immobilon-P PVDF membrane (#IPVH00010,
Merck). They were blocked in a 1% BSA solution (#9647,
Sigma), then probed with the following primary antibodies:
Bruchpilot 1:5000 (nc82, #2314866, DSHB), Discs-large 1:10,000
(4F3, #528203, DSHB), Neuroglian 1:5000 (BP104, #528402,
DSHB), and β tubulin 1:5000 (E7, #2315513, DSHB). Bands
were detected with goat anti-mouse, and goat anti-rabbit
horseradish peroxidase-linked secondary antibodies (#1706515
and #1721011, Bio-Rad) and Supersignal West Dura extended
duration chemiluminescence substrate (#34075, ThermoFisher).
Immunoblotting was done in triplicate. Density of bands was
quantified using Image J software (v1.51n). Analysis method
included cropping a standard size rectangular band around the
area of the blot of interest was selected and then the generated
histogram was cropped with a straight line at the base of the
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intensity peak—the resulting area under the curve was then
converted by image J to a numerical value which represented blot
density and was used for data analysis. Blot density was compared
to the density of the β tubulin loading control.
Flow Cytometry
Five fly brains were dissected in cold 1xPBS solution and
transferred to dissection media containing 7.5 mls of
DMEM (high glucose, HEPES, phenol-red free, #21063029,
ThermoFisher), 2.5 mls of 10x trypsin (#15400054,
ThermoFisher), and 1% BSA (#9647, Sigma). Brains were
washed in trypsin free dissection media, gently triturated using a
200 µL pipette 30 times, then filtered through a 70µM strainer.
The resulting solution was mixed in a 1:1 ratio with Annexin V &
dead cell solution (Annexin V & 7-AAD, #MCH100105, Merck),
incubated at room temperature for 20min, then processed
on the Muse Cell Analyser (Merck) using inbuilt analysis
software. Dilutions in trypsin free dissection media we made as
required. For positive controls brains were incubated in 200mM
of Actinomycin D (#A1410, Sigma) at 37◦C for 6 h before
processing. The average cell/ml concentration was 3.0 x 105 with
a range of 2.1 x 105 to 9.8 x 105 between groups. The MuseTM
Cell Analyzer system can detect cells sized between 2 and 60µm.
The flow cytometry data was obtained from 5,000 events (gated
cells) per sample. The percentages of cells shown in the figures
were calculated from the mean fluorescence intensity in each of
the four quadrants. Cell size was thresholded at a cell size index
of 1.5 to exclude cellular debris. Gating was kept constant for
all experiments—it was set on the two-parameter dot plot as
displayed. This is auto-optimized by the MuseTM Annexin V &
Dead Cell Kit (EMDMillipore).
Statistical Analysis
Statistical analysis and graph fitting was performed using
Graphpad Prism 7.02 (GraphPad Software Inc.). Statistical
tests and biological/technical repeats are listed in respective
figure legends—as a minimum all experiments were repeated in
triplicate. Significance threshold was taken as a p value< 0.05.
RESULTS
A Drosophila melanogaster High Impact
Trauma Device Produces a Quantifiable
Injury That Demonstrates
Genotype-Dependent Variation in
Early Survival
Tomodel TBI inD.Melanogasterwe utilized theHIT device. This
consists of a spring-loaded attachment that holds a polystyrene
vial of flies and inflicts a rapid acceleration-deceleration impact
injury [Supplementary Figure 2A—image from Katzenberger
et al. (38)]. The severity of injury correlated with the angle of
initial deflection of the device spring. An angle of 90◦ produced
an average death rate of 22% at 24 h and 30% at 7 days post-
injury in wild type (hiwWT) flies (Supplementary Figure 2B).
External injuries were never seen at angles of 90◦ or less but were
common (82%) at an angle of 135◦, therefore the 90◦ was chosen
to represent a single severe HIT in subsequent studies. Our choice
of HIT severity was also based on the observed incapacitation
rate–defined as the proportion of flies that demonstrated a
lack of purposeful movement 20 s or more following trauma.
The incapacitation rate was comparable in both hiwWT and
hiw1N , but when compared to a HIT at 90o, incapacitation
rate at 70o was greatly reduced (∼100% vs. ∼50%) and was
less consistent (Supplementary Figure 2C). Given this more
consistent evidence of neural injury, and the lack of evidence of
systemic injury at 90o, this HIT protocol was therefore chosen to
represent a single severe traumatic HIT in subsequent studies. In
order to minimize variability a single experimenter used the same
HIT device with the same setup for all impact experiments. A
visual marker was placed at the 90o position (when viewed from a
lateral viewpoint) this allowed an exact reproducible spring angle
each time.
The hiw1N flies have previously been reported as having
synaptic overgrowth at neuromuscular junctions but are
otherwise phenotypically normal (31, 36, 37, 44). We found that
in uninjured flies the genotype (hiwWT or hiw1N) did not have
any influence on long-term survival, indicating no significant
effect of the hiw null allele on baseline viability. HIT resulted
in an incapacitation rate that was the same in both hiwWT
and hiw1N and 24 h following a HIT both hiwWT and hiw1N
flies demonstrated reduced survival compared to uninjured flies
(Supplementary Figure 2D). However, notably the early death
rate was greater in hiw1N flies. The cause of this small excess
burden of death was not determined by this study. This may
reflect non-TBI related causes related to the constitutive loss of
hiw expression. Increased mortality following HIT could also
be due to traumatic intestinal barrier dysfunction. To exclude
this possibility flies were exposed to colored food post HIT and
examined for leakage of food dye (45). This demonstrated very
low rates of intestinal barrier breakdown regardless of genetic
background, supporting the conclusion that the HIT severity
we applied did not cause gross thoraco-abdominal trauma
(Supplementary Figure 2E).
High Impact Trauma Induced Long-Term
Mortality Is Reduced and Functional
Impairment Rescued by Loss of highwire
To determine if loss of hiw could protect against long-term
effects of TBI we examined survival in animals that lived
beyond the initial 24 h post injury period. Injury caused a
significant reduction in long-term survival in both hiwWT and
hiw1N animals compared to uninjured controls. However, hiw1N
animals demonstrated significantly increased survival following
injury compared to hiwWT , particularly from ∼20 days post
injury (Figure 1A). To determine if loss of hiw could rescue
injury-induced climbing deficits we used the rapid iterative
negative geotaxis (RING) assay (Supplementary Figure 2F) (41,
42). This demonstrated a significantly reduced climbing ability
after HIT in hiwWT flies, which was attenuated in those with a
hiw1N deletion (Figure 1B). We also examined motor function
by measuring flying ability. Flight behavior has been shown to
vary with the level of protocerebral anterior medial dopaminergic
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FIGURE 1 | Long-term mortality, climbing, and flying ability are relatively preserved in highwire mutants. (A) Mortality rates over lifetime of flies in hiw1N and hiwWT flies.
n = 6 vials of 20-35 flies per condition. Statistical analysis was with Log-rank test. ****p ≤ 0.0001. (B) Reduction in climbing ability compared to baseline in injured
versus uninjured hiw1N and hiwWT flies at 45 days post injury. n = 6 vials of 35 flies per condition. Statistical analysis was with two-way ANOVA test. *p ≤ 0.05. (C)
Percentage of time spent in flight over a 30 s period in injured versus uninjured hiw1N and hiwWT flies at 7 days post injury. n = 10-12 per condition. Statistical analysis
was with two-way ANOVA test. **p ≤ 0.01. Error bars show standard error of the mean for all experiments.
neurons (46). At 7 days following injury hiwWT show a significant
reduction in the percentage of time they spend in flight over a 30 s
period when compared to controls of their own genotype. This
deterioration in flying activity after injury is strikingly diminished
in the hiw1N flies (Figure 1C). Injured flies that do not have
flight activity still have healthy looking wings, make frequent
spontaneous wing movements, and engage in wing grooming
behavior, suggesting that the failure to fly even when provoked
by a stimulus of air is not simply as a result of a peripheral wing
injury. This is supported by the cases where short periods of
flight are initiated but the flies seem unable to maintain for a
prolonged duration.
Loss of highwire Reduces
Neuronal Apoptosis
In order to explore the mechanism of neuronal cell loss following
HIT we performed flow cytometry of dissociated fly brains
(Figures 2A,B). This demonstrated low-levels of baseline early
apoptosis (Annexin V positive, 7 AAD negative) and late
apoptosis/cell death (Annexin V positive and 7 AAD positive)
in hiwWT and hiw1N uninjured controls (<0.5%). In contrast,
7 days following injury there was a rise in both early apoptosis,
and late apoptosis/cell death by flow cytometry. This is direct
evidence for brain injury following impact with the HIT device.
The levels of early apoptosis were significantly lower in the hiw1N
flies compared to hiwWT following injury at 7 days, however the
absolute difference was small (∼0.5%). There were no significant
differences in late apoptosis/death at either time point. This
suggests that HIT causes a neuronal apoptotic cell death that is
rescued by hiw1N mutation.
Dopaminergic Neuron Loss Is Attenuated
by Loss of highwire
To explore the mechanisms underlying the protective effects
of hiw following TBI we performed histological studies on
fly brains. We first looked for evidence of injury-induced
neurodegeneration by quantifying brain vacuolation (38, 47–
49). Both hiwWT and hiw1N flies demonstrated an increase in
vacuolation at 28 days following injury, though no attenuation
of vacuolation was observed in hiw1N flies (Figure 3A).
We next examined a well-characterized subpopulation of
dopaminergic neurons (protocerebral posterior lateral 1 cluster,
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FIGURE 2 | Flow cytometry of dissociated drosophila brains shows necrosis but low levels of apoptosis after injury. (A) Flow cytometry demonstrating the percentage
of cells undergoing early apoptosis, and late apoptosis/cell death following injury at 24 h and 7 days in hiw1N and hiwWT flies. n =9. Error bars show standard error of
the mean. Statistical analysis was with two-way ANOVA test. **p ≤ 0.01. (B) Graphical representative flow cytometry data.
PPL1), which are involved in climbing and flying behavior
(Figure 3B) (46, 50, 51).
The number of neurons in the PPL1 cluster is remarkably
consistent in wild-type flies, with an average of 12 neurons.
Immunostaining for tyrosine hydroxylase (TH) demonstrated
a significant decrease in the number of neurons in the PPL1
cluster following injury in hiwWT flies. However, no reduction
in PPL1 neuron numbers was seen following injury in hiw1N
flies (Figures 3C,D).
Loss of highwire Reduces Synaptic Protein
Loss Following Injury
In order to probe the nature of underlying cellular responses
to the HIT we conducted western blots analysis using the
pan-neuronal marker Neuroglian (Ngl), the presynaptic marker
Bruchpilot (Brp), and the post synaptic maker Disc Large (Dlg)
at 24 h and 7 days following injury. After injury there was
a significant reduction in Ngl at 24 h in hiwWT indicating a
generalized loss of neurons. This trend was also seen at 7 days
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FIGURE 3 | Injured flies develop brain vacuoles regardless of genotype, but depletion of PPL1 cluster dopaminergic neurons that is prevented by highwire mutation.
(A) Rates of vacuolation seen by hematoxylin and eosin staining in central brain regions at 28 in hiw1N and hiwWT flies 28 days following injury. n = 5 per condition.
Error bars show standard error of the mean. Statistical analysis was with two-way ANOVA test. *p ≤ 0.05. (B) Representative hemotoxylin and eosin stained brain
sections from uninjured and injured hiwWT flies. The insert shows a close up of a typical vacuole. A further small vacuole is marked by an asterix. (C) Schematic image
(Continued)
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FIGURE 3 | and TH stained whole brain mount showing the location of various dopaminergic neuronal groups including the PPL1 cluster. (D) Number of TH-positive
PPL1 neurons in hiw1N and hiwWT flies at 28 days post injury. n = 10-12 clusters per condition. Error bars show standard error of the mean. Statistical analysis was
with two-way ANOVA test. **p ≤ 0.01. (E) Representative PPL1 dopaminergic neuronal clusters showing depleted neuron numbers in injured hiwWT flies (9 neurons)
and preserved numbers in injured hiw1N flies (12 neurons).
but was no longer significant. In contrast, hiw1N flies did not
have a reduction in Ngl. Mirroring the Ngl loss, Brp was also
reduced following injury at 24 h, but this reduction persisted at 7
days with some progressive loss. As with ngl, the hiw1N flies were
protected against Brp loss regardless of timepoint- and a non-
significant trend suggesting a possibly increase was seen. Finally,
Dlg levels were examined. Again, trends mirrored those of Ngl
and Brp, with small falls seen in the hiwWT , and small rises in
the hiw1N flies, but notably these were not significant in any
case (Figure 4).
DISCUSSION
Our results provide support for the hypothesis that a mutation
in the hiw gene (hiw1N) demonstrates protection against the
deleterious effects of HIT. The hiw1N mutation results in
a complete loss-of-function of highwire, leading to delayed
degradation of dNMNAT, a core step in the WD process.
The hiw1N mutation has previously been shown to strongly
delay WD both in vitro and in vivo (24, 31–33). In D.
Melanogaster, the hiw1N mutation protected against several
deleterious effects of a high-velocity impact trauma model.
Deaths were significantly reduced in keeping with longer-
term protection against secondary brain injury processes. Flies
with hiw1N mutation suffer less neurodegeneration following
HIT as manifest by reduced PPL1 dopaminergic neuron
loss. Dopaminergic neurons have previously been shown to
demonstrate selective vulnerability following brain injury and
in various neurodegenerative conditions including Parkinson’s
disease (50–53). Our investigation of dopaminergic neurons was
limited to the PPL1 subpopulation. Although the TH stain marks
other dopaminergic populations the PPL1 population is the
best characterized and has the small variability in its neuronal
number. This is not the case for other neuronal populations—
which are less consistent in their number, not as easy to reliably
count due to variability in density, and not as well characterized
in terms of relationship to function. The focus on PPL1 allowed
us the confidence that our staining technique was reliable and
comparable to pre-existing studies, and allowed us to robustly
detect differences due to injury or genetic modification. However,
as a result of this specific focus we cannot make comment about
the effect on other neuronal populations. In order to try and
address the limitation of only quantifying a small subpopulation
we looked for more general evidence of neuronal loss and
rescue with the vacuolation assay. Injury resulted in increased
vacuolation in all genotypes but interestingly this was not rescued
in the hiw1N mutants.
Given the well-characterized function of highwire in
dNMNAT degradation, the mechanisms for the protection
seen with hiw1N mutation are likely to directly involve the
Wallerian-like degeneration pathway, specifically through
maintenance of dNMNAT levels in the axonal compartment
and/or the cell body and delayed neuronal degeneration. As there
is only a single dNMNAT isoform in D. Melanogaster, a decline
in levels may cause death of both the axon and the cell body. An
important future experiment would be to assess dNMNAT levels
in a neuronally expressed HA-nmnat tagged fly system.
An alternative explanation would be that loss of highwire
function is maintaining dNMNAT levels that are then
functioning as a molecular chaperone, possibly through
alleviation of prototoxic stress (11, 12, 14, 15, 54). Given the
nature of the model system we cannot completely exclude
that the rescue of lifespan and behavior are not due to effects
outside of the CNS, however, the lack of external injuries, the
failure of the model to cause intestinal barrier dysfunction,
and the initial period of recovery and normal behavior
following injury argue against this. The hiw1N mutation is
constitutive, therefore there may be unrecognized systemic
effects beyond those we have characterized in the brain.
This could be addressed in future studies by examination
of a conditional mutant. We know that hiw1N flies have
previously been reported as having synaptic overgrowth at
neuromuscular junctions but are otherwise phenotypically
normal (31, 36, 37, 44). We cannot completely exclude the
possibility that there is a hitherto unrecognized underlying
phenotypic difference that we, and previous researchers have
failed to identify. As long as this possibility remains we
would urge caution in interpreting the results of this study
in isolation.
We did not find any alteration in the levels of synaptic proteins
in the uninjured hiw1N brains compared to wild-types in our
analysis. This suggests that the synaptic overgrowth effects seen
previously at the neuromuscular junction of hiw1N do not occur
in the brain. We demonstrated that HIT trauma resulted in
an excess of apoptotic cell death that was partially rescued by
hiw1N . This is an intriguing finding given that WD is a non-
apoptotic mechanism of axon degeneration. One possibility is
that absence of retrograde delivery of trophic factors by axonal
transport could trigger apoptosis of cell bodies—this hypothesis
requires further testing. Behavioral measures are less commonly
used and well-defined in flies compared to mammalian systems.
We chose to use two of the commonest and best characterized
in climbing and flying assays. The ability of hiw1N to prevent
injury induced climbing and flying defects may be explained
by dopaminergic neuron rescue, and PPL1 neuronal loss has
previously linked to climbing deficits (46, 51). The preferential
presynaptic protein loss seen on Western blot analysis is a
pattern that is established in neurodegenerative models (55,
56). dNMNAT has also been shown to maintain presynaptic
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FIGURE 4 | Injured flies demonstrate a loss of presynaptic marker protein that is prevented by highwire mutation. Levels of Neuroglian, Bruchpilot, or Disc large
relative to β tubulin loading control at 24 h and 7 days following injury in hiw1N and hiwWT flies. Representative blots are displayed. n = 5 per condition. Error bars
show standard error of the mean. Statistical analysis was with two-way ANOVA test. *p ≤ 0.05, ***p ≤ 0.001.
active zones by directly interacting with bruchpilot (57). This
is consistent with our finding that bruchpilot was relatively
preserved after injury in hiw1N . Together, the finding suggest
that HIT causes apoptotic and selective neuronal cell death and
presynaptic protein loss, and that highwire loss of function can
partially rescue these effects and their functional consequences.
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This helps establish highwire as a potential therapeutic target in
brain trauma.
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